Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:950 (10 November), doi:10.1136/bmj.39315.677396.BE
The BMA adds its voice to the call for universal childhood immunisation in the UK
| The first 150 words of the full text of this article appear below. |
Hepatitis B virus is a substantial threat to global health, with 360 million people chronically infected and more than 500 000 deaths each year from fulminant hepatitis, cirrhosis, and liver cancer.1 2 After a call by the World Health Organization for the global introduction of vaccine prevention programmes by 1997,3 82% of countries in the world had introduced universal hepatitis B immunisation by 2005, and at least 55% of the world's children are now receiving three doses of the vaccine.4
To date, the United Kingdom has not offered universal immunisation, so most of its citizens are susceptible to infection. At the June 2007 annual representatives meeting, the BMA voted in favour of adding its voice to those of other expert groups in the UK calling upon the Department of Health "to introduce the hepatitis B vaccine into the childhood schedule without further delay."
The main argument against introducing universal immunisation is
Andrew J Pollard, reader in paediatric infection and immunity
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Children's Hospital, Oxford OX3 9DU
andrew.pollard@paediatrics.ox.ac.uk
Read all Rapid Responses